ADRs in Focus: Shire rises on expanded Vyvanse approval - Forbes
|
ADRs in Focus: Shire rises on expanded Vyvanse approval
Forbes, NY - Apr 23, 2008 AP 04.23.08, 4:03 PM ET Shares of British drug maker Shire PLC rose Wednesday after its attention deficit hyperactivity disorder drug Vyvanse was approved … |
Find Out More:
Books:
- Last Child in the Woods: Saving Our Children from Nature-Deficit Disorder
- ADD and the College Student: A Guide for High School and College Students With Attention Deficit Disorder
- Attention Deficit Disorder: The Unfocused Mind in Children and Adults
- Ritalin Is Not The Answer: A Drug-Free, Practical Program for Children Diagnosed with ADD or ADHD
- Siblings of Children With Autism: A Guide for Familes (Topics in Autism)
April 28th, 2008
Vyvanse

Leave a Reply